TY - JOUR
T1 - The electrospray ionization - Mass spectra of erythromycin A obtained from a marine Streptomyces sp. mutant
AU - El-Bondkly, A.
AU - Abd-Alla, Howaida
AU - Shaaban, M.
AU - Shaaban, K.
PY - 2008/2/1
Y1 - 2008/2/1
N2 - In our ongoing search for production improvements of bioactive secondary metabolites from marine Streptomyces through the induction of mutations using UV light, out of 145 isolates, mutant 10/14 was able to produce potent antibacterial metabolites other than the parent strain as established by chromatographic analysis. Up-scaling fermentation of mutant 10/14, followed by working up and isolation delivered five metabolites, phenazine, 1-acetyl-β-carboline, perlolyrin and erythromycin A, along with an oily substance. The latter two compounds were responsible for the antibacterial activity of the strain. In this article, we discuss with the mutation of the marine Streptomyces sp. AH2, bioactivity evaluation, fermentation and isolation of the microbial metabolites. Moreover, we study to first time in detail the 1D and 2D NMR and ESI MS data including ESI MS2 and MS3 patterns combined with HRESI MS of erythromycin A.
AB - In our ongoing search for production improvements of bioactive secondary metabolites from marine Streptomyces through the induction of mutations using UV light, out of 145 isolates, mutant 10/14 was able to produce potent antibacterial metabolites other than the parent strain as established by chromatographic analysis. Up-scaling fermentation of mutant 10/14, followed by working up and isolation delivered five metabolites, phenazine, 1-acetyl-β-carboline, perlolyrin and erythromycin A, along with an oily substance. The latter two compounds were responsible for the antibacterial activity of the strain. In this article, we discuss with the mutation of the marine Streptomyces sp. AH2, bioactivity evaluation, fermentation and isolation of the microbial metabolites. Moreover, we study to first time in detail the 1D and 2D NMR and ESI MS data including ESI MS2 and MS3 patterns combined with HRESI MS of erythromycin A.
KW - Bioactivity evaluation
KW - ESI-MS/MS
KW - Erythromycin A
KW - Marine Streptomyces mutation
UR - http://www.scopus.com/inward/record.url?scp=52149097401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52149097401&partnerID=8YFLogxK
U2 - 10.4103/0250-474X.42979
DO - 10.4103/0250-474X.42979
M3 - Article
C2 - 20046738
AN - SCOPUS:52149097401
SN - 0250-474X
VL - 70
SP - 310
EP - 319
JO - Indian Journal of Pharmaceutical Sciences
JF - Indian Journal of Pharmaceutical Sciences
IS - 3
ER -